Acunac 0.0009 is a Product of the Generic Bromfenac Sodium

Acunac 0.0009 belongs to the generic category of Bromfenac Sodium. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of Acunac 0.0009. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Bromfenac Sodium and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of Acunac 0.0009

Acunac 0.0009 may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of Acunac 0.0009 is provided below to help users gain a clear understanding of this medicine.

What Is Acunac 0.0009 Indications and Uses?

Bromfenac ophthalmic solution is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.

Pharmacology (Source, Chemical and Physical Composition) Of Acunac 0.0009

Bromfenac is a nonsteroidal anti-inflammatory drug (NSAID) that has anti-inflammatory activity. The mechanism of its action is thought to be due to its ability to block prostaglandin synthesis by inhibiting cyclooxygenase 1 and 2. Prostaglandins have been shown to be mediators of certain kinds of intraocular inflammation. In studies performed in animal eyes, prostaglandins have been shown to produce disruption of the blood-aqueous humor barrier, vasodilatation, increased vascular permeability, leukocytosis, and increased intraocular pressure.

Dosage And Administration of Acunac 0.0009

For the treatment of postoperative inflammation in patients who have undergone cataract extraction, one drop of ophthalmic solution should be applied to the affected eye(s) once daily beginning 1 day prior to cataract surgery, continued on the day of surgery, and through the first 14 days of the postoperative period.

Side Effects of Acunac 0.0009

The most commonly reported adverse experiences include: abnormal sensation in eye, conjunctival hyperemia, eye irritation (including burning/stinging), eye pain, eye pruritus, eye redness, headache, and iritis.

Use During Pregnancy and Lactation

Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. This drug should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. Caution should be exercised when Bromfenac ophthalmic solution is administered to a nursing woman.

Precautions And Warnings for Acunac 0.0009

All topical NSAIDs may slow or delay healing. Topical corticosteroids are also known to slow or delay healing. Concomitant use of topical NSAIDs and topical steroids may increase the potential for healing problems. It is recommended that Bromfenac ophthalmic solution be used with caution in patients with known bleeding tendencies or who are receiving other medications which may prolong bleeding time

Therapeutic Class

Ophthalmic Non-Steroid drugs

Storage Conditions of It

Store in a cool (below 30°C), dry place and away from light. Keep out of reach of children. To prevent contamination of the dropper tip and solution, care should be taken. Don't touch the eyelids, surrounding areas, finger or other surfaces with the dropper tip of the bottle. The bottle should be tightly closed when not in use. Do not use after 4 weeks of first opening.